Dr. Field is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UH Cleveland Medical Center
11100 Euclid Ave Department of Medicine-Endocrinology
Cleveland, OH 44106Phone+1 216-844-8500Fax+1 216-844-3120
Education & Training
- Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1997 - 1999
- Harvard Medical SchoolClass of 1997
Certifications & Licensure
- CA State Medical License 2005 - 2026
- OH State Medical License 2020 - 2026
- MA State Medical License 1999 - 2005
- PA State Medical License 1998 - 1999
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- 457 citationsPhosphoinositide signalling links O -GlcNAc transferase to insulin resistanceXiaoyong Yang, Pat P. Ongusaha, Philip D.G. Miles, Joyce C. Havstad, Fengxue Zhang
Nature. 2008-02-21 - 309 citationsReceptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and ProgressionMichael C. Schmid, Christie J. Avraamides, Holly C. Dippold, Irene Franco, Philippe Foubert
Cancer Cell. 2011-06-14 - 132 citationsMutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity.Matilde Murga, Oskar Fernández-Capetillo, Seth J. Field, Bernardino Moreno, Luis R.-Borlado
Immunity. 2001-12-01
Grant Support
- Targeting A Novel Phosphoinositide Signaling Pathway For Cancer TherapyNational Cancer Institute2009–2010
- Phosphoinositides Provide Unique Insights Into Cell Biology And PathophysiologyOffice Of The Director, National Institutes Of Health2008
- Pi-3-Kinase Signaling Over Physiologic Time-Scales/Response To Insulin Or IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2006–2007
- Pi-3-Kinase Mediated Signaling By Insulin And IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2004–2007
- Pi-3-Kinase Mediated Signaling By Insulin And IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: